Intesa invests 360 million euros to manage its entire health insurance business

Published Date: 08 Mar 2023

Italy's biggest conglomerate, Intesa Sanpaolo, has paid 360 million euros ($382 million) in cash to acquire a 26.2% stake in health insurer Intesa Sanpaolo RBM Salute, which it does not own. that it will be used.

Read Full News

Latest News

Sandoz Files European Complaint About Chinese Antibiotic Imports

Swiss generic drugmaker Sandoz filed a draft ⁠anti-dumping complaint with the European Commission over Chinese imports ⁠of the antibiotic ingredient amoxicillin.

What Your ZIP Code Is Costing You

Forget salary. The cities winning the physician satisfaction race are playing a completely different game.

How NPs Are Navigating Prior Authorization Coverage Barriers

The same hurdles facing physicians slow treatment for nurse practitioners’ patients, and the impact on care continues.

US FDA Issues Recall Of Boston Scientific Heart Devices

Boston Scientific has issued an urgent recall to correct several heart devices after ⁠the U.S. Food and Drug Administration classified the action as its most serious recall,...

Delays in Visa Program Threaten Hundreds of Doctors

Prolonged HHS J-1 waiver backlogs leave hundreds of foreign-trained doctors facing departure this summer, threatening care in underserved areas, immigration attorneys warn.

AstraZeneca to Invest $405 Million in Britain After US-UK Pharma Deal

Prime Minister Keir Starmer said on Wednesday that Britain's biggest company AstraZeneca would invest 300 million pounds ($405 ⁠million) in the country, after pausing...

Todays Updates

Isatuximab Boosts MRD Negativity in Multiple Myeloma

Researchers compare two different treatment regimens in 446 transplant-ineligible patients with newly diagnosed multiple myeloma in a global phase 3 trial.

Novel ADC Improves Survival in Metastatic TNBC

Izalontamab brengitecan extends overall survival among patients with metastatic TNBC, but it’s unclear how the investigational therapy might fit into an evolving treatment landscape.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

For men with localized prostate cancer, proton therapy looks no better than IMRT when it comes to 3-year biochemical progression or GI toxicity.

Fuzuloparib Add-On Improves Metastatic Prostate Cancer rPFS

Researchers track progression-free survival after adding a PARP inhibitor to a standard regimen for metastatic castration-resistant prostate cancer.

Todays Updates

Isatuximab Boosts MRD Negativity in Multiple Myeloma

Researchers compare two different treatment regimens in 446 transplant-ineligible patients with newly diagnosed multiple myeloma in a global phase 3 trial.

Novel ADC Improves Survival in Metastatic TNBC

Izalontamab brengitecan extends overall survival among patients with metastatic TNBC, but it’s unclear how the investigational therapy might fit into an evolving treatment landscape.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

For men with localized prostate cancer, proton therapy looks no better than IMRT when it comes to 3-year biochemical progression or GI toxicity.

Fuzuloparib Add-On Improves Metastatic Prostate Cancer rPFS

Researchers track progression-free survival after adding a PARP inhibitor to a standard regimen for metastatic castration-resistant prostate cancer.

Latest News

Swiss generic drugmaker Sandoz filed a draft ⁠anti-dumping complaint with the European Commission over Chinese imports ⁠of the antibiotic ingredient amoxicillin.

Forget salary. The cities winning the physician satisfaction race are playing a completely different game.

The same hurdles facing physicians slow treatment for nurse practitioners’ patients, and the impact on care continues.

Boston Scientific has issued an urgent recall to correct several heart devices after ⁠the U.S. Food and Drug Administration classified the action as its most serious recall,...

Prolonged HHS J-1 waiver backlogs leave hundreds of foreign-trained doctors facing departure this summer, threatening care in underserved areas, immigration attorneys warn.

Prime Minister Keir Starmer said on Wednesday that Britain's biggest company AstraZeneca would invest 300 million pounds ($405 ⁠million) in the country, after pausing...

News All Time

US Proposes Easing Limits on Cancer-causing Gas Used to Clean Medical Devices

The Trump administration is proposing to lift some limits on the use of ethylene oxide, a carcinogenic gas used ⁠for sterilization, saying previous constraints imposed under...

BMA Warns Scottish Medical Schools ‘Beyond Capacity’

Medical student numbers in Scotland have risen 72% since 2015, but teaching capacity and training posts have not kept pace, a BMA report warns.

Federal Loan Caps Will Reduce PA School Applicants

Proposed federal student loan caps will drive students into pricier private loans, or derail their aspirations of becoming PAs, creating professional healthcare shortages.

The Golden Handcuffs of Private Equity

Private equity firms are increasingly buying up smaller medical practices. Sometimes for the better, and sometimes not.

New Book Spotlights Medicine’s Emotional Side

A new anthology, Where It Hurts: Dispatches from the Emotional Frontlines of Medicine, explores how doctors process the day-to-day challenges of their careers.

Novel imaging approach may improve treatment for spinal cord injuries

Northwestern Medicine investigators have developed a new imaging approach to more accurately assess blood flow in the spinal cord, a method that could be used to better inform treatment for neurological diseases and injuries, ...

Tirzepatide may only temporarily suppress brain 'food noise' activity

A rare glimpse into the brain activity of a patient with obesity and loss of control eating on tirzepatide, marketed as Mounjaro and Zepbound, revealed that the medication suppresses signaling in the brain's "reward center" ...

Supercomputer simulation is changing how we study the brain

Harnessing the muscle of one of the world's fastest supercomputers, researchers have built one of the largest and most detailed biophysically realistic brain simulations of an animal ever.

AI tool creates digital twins of patients to predict their future health

A new artificial intelligence tool that can create virtual representations of patients and predict individual health trajectories has been hailed a potential gamechanger for the clinical trial sector.

New tool predicts graft failure after kidney transplant

Researchers at The Johns Hopkins Medicine say they have developed a new electronic medical records-based tool that should help doctors predict which patients are most at risk of losing a transplanted kidney graft.

How are patients using health care chatbots? Study finds some 'eye-openers'

A health care chatbot can be a patient's first point of contact for some sensitive conversations from mental health to billing, a new CU Anschutz study has found.

New study reveals high rates of fabricated and inaccurate citations in LLM-generated mental health research

A new study published in the journal JMIR Mental Health by JMIR Publications highlights a critical risk in the growing use of Large Language Models (LLMs) like GPT-4o by researchers: the frequent fabrication and inaccuracy ...

A unified model of memory and perception: How Hebbian learning explains our recall of past events

A collaboration between SISSA's Physics and Neuroscience groups has taken a step forward in understanding how memories are stored and retrieved in the brain. The study, recently published in Neuron, shows that distinct perceptual ...

Malaria rapid diagnostic test 'not fit for purpose,' international study claims

An international study published in the Malaria Journal claims that a widely used test for detecting malaria is delivering too many inaccurate false-negative results and is "not fit for purpose."

Ovarian tissue preservation enables future fertility for young woman with cancer

In patients of reproductive age who have cancer, fertility preservation for potential children in the future should be a high priority. A practice article published in the Canadian Medical Association Journal describes the ...

Simple test brings clarity and hope for families with inherited neuropathy

A new, inexpensive urine test that measures two sugar alcohols, sorbitol and xylitol, is making it easier, faster, and far less expensive to identify a common inherited nerve disorder called SORD-related neuropathy. The test, ...

Recommended News For You

FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma

Recent Rise in Early-Onset Solid Tumors Is Associated with Accelerated Aging.

Basal stem-like cells identified as origin of small cell lung cancer in lab models

Worse Outcomes After Esophagectomy at Private Equity-Owned Hospitals

Study finds higher breast cancer rates in areas with more air pollution

Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.

Mammography with AI support is a secure method for detecting breast cancer.

Recommended Articles For You

AI in the War on Cancer: How Digital Tools are Revolutionizing Oncology 

Clinical Analysis of Prostate Cancer 

Unlocking the Secrets of Improved Ovarian Cancer Survival Rates 

Exploring the Impact of Adrenal Myelolipoma on the Human Body 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.

2.

FDA Greenlights First Engineered Cell Therapy for a Solid Tumor

3.

The FDA Approves the New Frontline Aggressive ALL Regimen.

4.

Studies point to redlining as a 'perfect storm' for breast cancer

5.

Targeted radiation therapy shows near-complete response in rare sarcoma patients

1.

The Power of Salt Tablets: Unlocking Health Benefits Beyond Sodium

2.

Neuroendocrine Tumors: Mechanisms of Mortality, Associated Conditions

3.

Revolutionizing Thyroid Cancer: Advances in Molecular Genetics and Personalized Treatment Approaches

4.

Seeing the Unseen: The Benefits of Early Stage Breast Cancer Ultrasound

5.

Unlocking the Secrets of Follicular Cells: Exploring the Potential of Stem Cell Research

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

International Lung Cancer Congress®

3.

Genito-Urinary Oncology Summit 2026

4.

Future NRG Oncology Meeting

5.

ISMB 2026 (Intelligent Systems for Molecular Biology)

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III

3.

Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL

4.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI

5.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot